Trial of OTD70DERM® in Radio-dermatitis Induced by Radiotherapy-Erbitux®

Clinical trial NCT01228565 · COMPLETED

Trial details

NCT number: NCT01228565
Sponsor: Groupe Oncologie Radiotherapie Tete et Cou
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Head and Neck Carcinoma

Start date: 2010-08-01
Primary completion: 2014-05-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.